HUE045679T2 - Valentonint tartalmazó transzdermális terápiai rendszer, és annak alkalmazása gyógyszerként - Google Patents
Valentonint tartalmazó transzdermális terápiai rendszer, és annak alkalmazása gyógyszerkéntInfo
- Publication number
- HUE045679T2 HUE045679T2 HUE16703289A HUE16703289A HUE045679T2 HU E045679 T2 HUE045679 T2 HU E045679T2 HU E16703289 A HUE16703289 A HU E16703289A HU E16703289 A HUE16703289 A HU E16703289A HU E045679 T2 HUE045679 T2 HU E045679T2
- Authority
- HU
- Hungary
- Prior art keywords
- valentonin
- medicament
- system containing
- therapeutic system
- transdermal therapeutic
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15305161 | 2015-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE045679T2 true HUE045679T2 (hu) | 2020-01-28 |
Family
ID=52573642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16703289A HUE045679T2 (hu) | 2015-02-04 | 2016-02-04 | Valentonint tartalmazó transzdermális terápiai rendszer, és annak alkalmazása gyógyszerként |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10744122B2 (enExample) |
| EP (1) | EP3253378B1 (enExample) |
| JP (1) | JP6785779B2 (enExample) |
| KR (1) | KR102361801B1 (enExample) |
| CN (1) | CN107810003B (enExample) |
| CA (1) | CA2975985A1 (enExample) |
| ES (1) | ES2738633T3 (enExample) |
| HU (1) | HUE045679T2 (enExample) |
| WO (1) | WO2016124688A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2116036A1 (en) * | 1991-10-18 | 1993-04-29 | F. Eugene Yates | Device for the transdermal administration of melatonin |
| DE4134493A1 (de) * | 1991-10-18 | 1993-04-22 | Teves Gmbh Alfred | Blockiergeschuetzte hydraulische bremsanlage |
| FR2724384B1 (fr) * | 1994-09-14 | 1999-04-16 | Cemaf | Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament |
| WO2001013950A1 (en) * | 1999-08-20 | 2001-03-01 | Takeda Chemical Industries, Ltd. | Percutaneous absorption agents |
| IL155666A (en) * | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
| FR2898358B1 (fr) * | 2006-03-08 | 2008-05-30 | Macef Sa | Association d'un antagoniste du recepteur 5ht2 et d'activateur du recepteur 5ht2 par modulation allosterique et leurs utilisations comme produits medicaux |
| FR2912405A1 (fr) * | 2007-02-08 | 2008-08-15 | Fourtillan Snc | Derives des imidazo[1',5':1,6]pyrido[3,4-b]indoles et leur utilisation en therapeutique |
-
2016
- 2016-02-04 KR KR1020177024343A patent/KR102361801B1/ko not_active Expired - Fee Related
- 2016-02-04 CN CN201680019543.5A patent/CN107810003B/zh not_active Expired - Fee Related
- 2016-02-04 ES ES16703289T patent/ES2738633T3/es active Active
- 2016-02-04 EP EP16703289.5A patent/EP3253378B1/fr active Active
- 2016-02-04 US US15/548,502 patent/US10744122B2/en not_active Expired - Fee Related
- 2016-02-04 WO PCT/EP2016/052376 patent/WO2016124688A1/fr not_active Ceased
- 2016-02-04 JP JP2017541869A patent/JP6785779B2/ja not_active Expired - Fee Related
- 2016-02-04 CA CA2975985A patent/CA2975985A1/fr not_active Abandoned
- 2016-02-04 HU HUE16703289A patent/HUE045679T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2975985A1 (fr) | 2016-08-11 |
| CN107810003A (zh) | 2018-03-16 |
| US10744122B2 (en) | 2020-08-18 |
| KR20180004100A (ko) | 2018-01-10 |
| JP6785779B2 (ja) | 2020-11-18 |
| ES2738633T3 (es) | 2020-01-24 |
| CN107810003B (zh) | 2022-05-03 |
| JP2018507850A (ja) | 2018-03-22 |
| US20180000796A1 (en) | 2018-01-04 |
| EP3253378A1 (fr) | 2017-12-13 |
| KR102361801B1 (ko) | 2022-02-10 |
| WO2016124688A1 (fr) | 2016-08-11 |
| EP3253378B1 (fr) | 2019-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258931A (en) | Medicinal compounds and methods | |
| IL253123A0 (en) | Preparations for administration through the skin and their uses | |
| GB201403093D0 (en) | Therapeutic compounds and their use | |
| IL254552A0 (en) | Polycyclic carbamoylpyridone compounds and their pharmaceutical uses | |
| GB201420039D0 (en) | System for training a user in administering a medicament | |
| GB201503961D0 (en) | A transdermal drug administration device | |
| ZA201802033B (en) | Heteroaryl compounds and their use as therapeutic drugs | |
| ZA201802256B (en) | Compounds and therapeutic uses thereof | |
| EP3263155A4 (en) | Drug solution administering device | |
| GB201617064D0 (en) | Compounds and their therapeutic use | |
| GB201502412D0 (en) | Therapeutic use | |
| ZA201703976B (en) | Dihydropyrimidine-2-one compounds and medicinal uses thereof | |
| IL247969B (en) | A medicinal component for use in the treatment of infections | |
| GB201406172D0 (en) | Therapy and pharmaceutical composition | |
| IL248962A0 (en) | Device and method for administering drugs to the brain | |
| HUE045185T2 (hu) | Új terápiás vegyület és terápiában történõ alkalmazása | |
| GB201519644D0 (en) | Therapy and pharmaceutical composition | |
| SI3294253T1 (sl) | Naprava za rekonstituiranje in apliciranje zdravil | |
| GB201506786D0 (en) | Therapeutic use | |
| HUE045679T2 (hu) | Valentonint tartalmazó transzdermális terápiai rendszer, és annak alkalmazása gyógyszerként | |
| GB201410387D0 (en) | Compounds and their therapeutic use | |
| GB201403496D0 (en) | Compounds and their therapeutic use |